5 Easy Facts About Ponsegromab Described
All enrolled people who obtained at least one particular dose of zosuquidar or placebo throughout induction have been monitored with the occurrence of adverse functions (439 clients, 219 on zosuquidar and 210 on placebo). The most common adverse activities ended up related to the duration of extended and substantial myelosuppression as is expected